Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 26 articles: HTML format

Single Articles

June 2025
1. RAMASWAMY S, Akiyama H, Berrigan J, Quinones-Molina AA, et al
   The macrophage-intrinsic MDA5-IRF5 axis drives HIV-1 intron-containing RNA-induced inflammatory responses.
   J Clin Invest. 2025 Jun 10:e187663. doi: 10.1172/JCI187663.
   PubMed     Abstract available
   
   
   
2. DESAI SS, Salahuddin S, Yusuf R, Ranjan K, et al
   Tumor microenvironment of non-small cell lung cancer impairs immune cell function among people with HIV.
   J Clin Invest. 2025 Jun 3:e177310. doi: 10.1172/JCI177310.
   PubMed     Abstract available
   
   
   May 2025
3. MACHMACH K, N'guessan KF, Farmer R, Godbole S, et al
   NK cell activation and CD4 T cell alpha4beta7 expression are associated with susceptibility to HIV-1.
   J Clin Invest. 2025 May 8:e187992. doi: 10.1172/JCI187992.
   PubMed     Abstract available
   
   
   April 2025
4. IMAMICHI H, Natarajan V, Scrimieri F, Smith M, et al
   Widespread distribution of transcriptionally active, clonally expanded, HIV-1 proviruses despite suppressive antiretroviral therapy.
   J Clin Invest. 2025 Apr 22:e190824. doi: 10.1172/JCI190824.
   PubMed     Abstract available
   
   
   
5. PAL PB, Iyer SS
   Transient pain and long-term gain: adjuvant dose directs immune memory.
   J Clin Invest. 2025;135:e190524.
   PubMed     Abstract available
   
   
   
6. VIOLARI A, Otwombe K, Hahn W, Chen S, et al
   Safety and implementation of phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.
   J Clin Invest. 2025 Apr 3:e186927. doi: 10.1172/JCI186927.
   PubMed     Abstract available
   
   
   
7. SETIABUDIAWAN TP, Hill PC, DiNardo AR, van Crevel R, et al
   Insights into protection against Mycobacterium tuberculosis infection: time to officially confirm another phenotype?
   J Clin Invest. 2025;135:e191423.
   PubMed     Abstract available
   
   
   March 2025
8. MACLEAN F, Tsegaye AT, Graham JB, Swarts JL, et al
   Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract.
   J Clin Invest. 2025 Mar 25:e184609. doi: 10.1172/JCI184609.
   PubMed     Abstract available
   
   
   
9. KATUSIIME MG, Neer V, Guo S, Patro SC, et al
   Divergent populations of HIV-infected naive and memory CD4+ T-cell clones in children on antiretroviral therapy.
   J Clin Invest. 2025 Mar 6:e188533. doi: 10.1172/JCI188533.
   PubMed     Abstract available
   
   
   
10. RAMEZANI-RAD P, Marina-Zarate E, Maiorino L, Myers A, et al
    The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in non-human primates.
    J Clin Invest. 2025 Mar 4:e185292. doi: 10.1172/JCI185292.
    PubMed     Abstract available
    
    
    February 2025
11. MU W, Tomer S, Harding J, Kedia N, et al
    Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo.
    J Clin Invest. 2025 Feb 11:e185489. doi: 10.1172/JCI185489.
    PubMed     Abstract available
    
    
    January 2025
12. TADDESE M, Grudda T, Belluccini G, Anderson M, et al
    Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment.
    J Clin Invest. 2025 Jan 30:e184243. doi: 10.1172/JCI184243.
    PubMed     Abstract available
    
    
    
13. DALLMANN-SAUER M, Fava VM, Malherbe ST, MacDonald CE, et al
    Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli.
    J Clin Invest. 2025 Jan 21:e188016. doi: 10.1172/JCI188016.
    PubMed     Abstract available
    
    
    December 2024
14. LEE MJ, Yeon JH, Lee J, Kang YH, et al
    Senescence of endothelial cells increases susceptibility to Kaposi's sarcoma-associated herpesvirus infection via CD109-mediated viral entry.
    J Clin Invest. 2024 Dec 12:e183561. doi: 10.1172/JCI183561.
    PubMed     Abstract available
    
    
    November 2024
15. GONZALEZ-NAVARRO I, Urrea V, Galvez C, Garcia-Guerrero MDC, et al
    Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.
    J Clin Invest. 2024 Nov 29:e183952. doi: 10.1172/JCI183952.
    PubMed     Abstract available
    
    
    October 2024
16. DURAND CM, Redd AD
    HOPE springs eternal: lack of HIV superinfection in HIV Organ Policy Equity Act kidney transplants.
    J Clin Invest. 2024;134:e184326.
    PubMed     Abstract available
    
    
    
17. MANNING MR, Blazkova J, Justement JS, Shi V, et al
    Timing of antiretroviral therapy initiation affects intact HIV reservoirs following analytical treatment interruption.
    J Clin Invest. 2024;134:e181632.
    PubMed    
    
    
    
18. KINCER LP, Dravid A, Trunfio M, Calcagno A, et al
    Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation.
    J Clin Invest. 2024;134:e176358.
    PubMed     Abstract available
    
    
    September 2024
19. MIHEALSICK E, Word A, Scully EP
    The impact of sex on HIV immunopathogenesis and therapeutic interventions.
    J Clin Invest. 2024;134:e180075.
    PubMed     Abstract available
    
    
    
20. TRAVIESO T, Stadtler H, Alavian N, Gao F, et al
    Longitudinal analysis of viral dynamics in HIV+ to HIV+ HOPE Act kidney-transplant recipients.
    J Clin Invest. 2024 Sep 10:e181560. doi: 10.1172/JCI181560.
    PubMed     Abstract available
    
    
    July 2024
21. KLOTMAN ME, Haynes BF
    The other pandemic: lessons from 40 years of HIV research.
    J Clin Invest. 2024;134:e183039.
    PubMed    
    
    
    June 2024
22. JOY J, Gervassi AL, Chen L, Kirshenbaum B, et al
    Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation.
    J Clin Invest. 2024 Jun 4:e159569. doi: 10.1172/JCI159569.
    PubMed     Abstract available
    
    
    May 2024
23. TEBAS P, Jadlowsky JK, Shaw PA, Tian L, et al
    CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
    J Clin Invest. 2024;134:e181576.
    PubMed    
    
    
    April 2024
24. WHITEHILL GD, Joy J, Marino FE, Krause RJ, et al
    Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1.
    J Clin Invest. 2024 Apr 23:e176673. doi: 10.1172/JCI176673.
    PubMed     Abstract available
    
    
    
25. EICHHOLZ K, Fukazawa Y, Peterson CW, Haeseleer F, et al
    Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.
    J Clin Invest. 2024;134:e169309.
    PubMed     Abstract available
    
    
    March 2024
26. ELIZALDI SR, Hawes CE, Verma A, Shaan Lakshmanappa Y, et al
    Chronic SIV-induced neuroinflammation disrupts CCR7+CD4+ T cell immunosurveillance in the rhesus macaque brain.
    J Clin Invest. 2024 Mar 12:e175332. doi: 10.1172/JCI175332.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.